NCT02251314
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Clinical trial condition
Neuroectodermal Tumors
Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.
6,011 public trials
1,221 recruiting studies
Neuroectodermal Tumors trial results
NCT00576537
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +7 more
- Locations
-
- Cedars Sinai Medical center Los Angeles, California, United States
NCT01313936
- Conditions
- Disease Attributes, Neoplasms, Neoplasms by Histologic Type, +11 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT01109095
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Texas Children's Hospital Houston, Texas, United States
NCT00984074
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Cranial Nerve Diseases, +24 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
Completed
Tolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-old
NCT03155217
- Conditions
- Melanoma, Metastatic Melanoma, Neoplasms, +10 more
- Locations
-
- Uhmontpellier Montpellier, France
NCT03791346
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
- Locations
-
- Uhmontpellier Montpellier, France
NCT00093964
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Barrow Neurological Institute Phoenix, Arizona, United States
- UCLA Medical Center Los Angeles, California, United States
- Denise Damek Aurora, Colorado, United States
NCT01590199
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
- Locations
-
- Novartis Investigative Site Bad Berka, Germany
- Novartis Investigative Site Berlin, Germany
- Novartis Investigative Site Münster, Germany
Completed
Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
NCT00961090
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +14 more
- Locations
-
- Allegheny General Hospital Pittsburgh, Pennsylvania, United States